Evidence map›Paper›PMID 32231164›Full record

ArticlePharmacy (Basel, Switzerland)2020

A Continuing Professional Development Program for Pharmacists Implementing Pharmacogenomics into Practice.

Natalie Crown, Beth A Sproule, Miles J Luke, Micheline Piquette-Miller, Lisa M McCarthy

Open access · goldAbstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Implementation of Pharmacogenetics in the United Kingdom.Handbook of experimental pharmacology · 2023
    Article
  10. An objective evaluation of fundamental pharmacogenomics knowledge among pharmacists and pharmacy students.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Natalie CrownLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, M5S 3M2, Canada.
Beth A SprouleLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, M5S 3M2, Canada.
Miles J LukePharmacy Services, Women's College Hospital, Toronto, M5S 1B2, Canada.
Micheline Piquette-MillerLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, M5S 3M2, Canada.
Lisa M McCarthyLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, M5S 3M2, Canada.ORCID 0000-0001-9087-1077
University of Toronto · CACentre for Addiction and Mental Health · CAWomen's College Hospital · CA

Funding

Canadian Foundation for Pharmacy Innovation Fund Grant
6 · The paper itself

Abstract

A continuing professional development (CPD) program for pharmacists practicing in community and team-based primary care settings was developed and evaluated using Moore's framework for the assessment of continuing medical education. The program had three components: online lectures, a two-day training workshop, and patient case studies. Knowledge (pre-post multiple choice test); attitudes, readiness, and comfort with applying pharmacogenomics in their practices (pre-post surveys); and experiences of implementing pharmacogenomics in practice (semi-structured interviews) were assessed. Twenty-one of 26 enrolled pharmacists successfully completed the program, and were satisfied with their experience. Almost all achieved a score of 80% or higher on the post-training multiple choice test, with significantly improved scores compared to the pre-training test. Pre- and post-training surveys demonstrated that participants felt that their knowledge and competence increased upon completion of the training. In the follow-up, 15 pharmacists incorporated pharmacogenomics testing into care for 117 patients. Ten pharmacists participated in semi-structured interviews, reporting strong performance in the program, but some difficulty implementing new knowledge in their practices. This multi-component CPD program successfully increased pharmacists' knowledge, readiness, and comfort in applying pharmacogenomics to patient care in the short-term, yet some pharmacists struggled to integrate this new service into their practices.

Indexed as

continuing educationcontinuing professional developmentpharmacistspharmacogenomicspharmacy

Identifiers

PMID32231164
PMCPMC7356265
OpenAlexW3013155735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.